Galapagos NV (GLPG)
27.73
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 6-K Lakefront Biotherapeutic For: Aug 25
August 25, 2026 4:31 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Aug 25
August 25, 2026 10:29 AM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Aug 25
August 25, 2026 10:26 AM - SEC Filing
Keymed Biosciences Announces 2026 H1 Results and Business Updates
August 20, 2026 10:10 AM - PR NewsWire
Form 6-K Lakefront Biotherapeutic For: Aug 18
August 18, 2026 4:38 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Aug 12
August 12, 2026 4:45 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Aug 12
August 12, 2026 7:59 AM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Aug 04
August 4, 2026 5:28 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jul 28
July 28, 2026 4:22 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jul 21
July 21, 2026 4:29 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jul 14
July 15, 2026 6:17 AM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jul 13
July 13, 2026 4:33 PM - SEC Filing
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
July 13, 2026 4:01 PM - Globe NewsWire
Form 6-K Lakefront Biotherapeutic For: Jul 07
July 7, 2026 4:25 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jun 30
June 30, 2026 4:37 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jun 29
June 30, 2026 6:02 AM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jun 23
June 24, 2026 6:05 AM - SEC Filing
Form SCHEDULE 13G Lakefront Biotherapeutic Filed by: Madison Avenue Partners, LP
June 23, 2026 6:50 PM - SEC Filing
Form 6-K Lakefront Biotherapeutic For: Jun 16
June 16, 2026 4:27 PM - SEC Filing
Full Article List